Access Pharmaceuticals, Inc. Stock OTC Bulletin Board
Stocks
ACCP
US00431M3088
Pharmaceuticals
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 08-14 | Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating | MT |
| 08-13 | Abeona Therapeutics Shares Fall After Q2 Miss | MT |
| Market Cap | 339M 292M 274M 251M 468M 32.06B 471M 3.24B 1.26B 16.38B 1.27B 1.25B 52.76B | P/E 2026 * |
-6.21x | P/E 2027 * | -31.5x |
|---|---|---|---|---|---|
| Enterprise Value | 339M 292M 274M 251M 468M 32.06B 471M 3.24B 1.26B 16.38B 1.27B 1.25B 52.76B | EV / Sales 2026 * |
6.24x | EV / Sales 2027 * | 2.85x |
| Free-Float |
79.59% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Access Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 50 | 15/10/2021 |
Joseph Vazzano
DFI | Director of Finance/CFO | 42 | 14/03/2022 |
James A. Gow
CTO | Chief Tech/Sci/R&D Officer | - | 20/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 58 | 01/03/2006 |
Faith Charles
BRD | Director/Board Member | 64 | 25/03/2021 |
Leila Alland
BRD | Director/Board Member | 63 | 19/04/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.99% | +5.63% | +47.90% | +1.94% | 84.22B | |
| -0.57% | +1.27% | -17.24% | -34.99% | 60.48B | |
| -4.07% | +4.81% | +495.65% | +32.25% | 59.43B | |
| -1.60% | -7.34% | -5.08% | +31.05% | 50.31B | |
| -3.85% | -1.99% | +3.71% | +159.67% | 48.91B | |
| -1.96% | +1.27% | +58.11% | -16.91% | 33.17B | |
| -0.71% | +2.22% | +48.79% | +100.90% | 25.95B | |
| -0.19% | -4.74% | +2.30% | +196.81% | 22.78B | |
| -1.35% | -2.49% | +65.91% | +110.66% | 16.73B | |
| Average | -1.69% | +0.47% | +77.79% | +64.60% | 44.66B | |
| Weighted average by Cap. | -1.83% | +1.40% | +91.36% | +44.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 54.34M 46.75M 43.87M 40.14M 74.92M 5.14B 75.51M 519M 202M 2.62B 204M 200M 8.45B | 119M 102M 95.97M 87.81M 164M 11.24B 165M 1.14B 442M 5.74B 446M 437M 18.49B |
| Net income | -54.51M -46.9M -44.01M -40.27M -75.16M -5.15B -75.75M -521M -203M -2.63B -205M -200M -8.48B | -9.22M -7.93M -7.44M -6.81M -12.71M -871M -12.81M -88.05M -34.29M -445M -34.62M -33.86M -1.43B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ABEO Stock
- ACCP Stock
Select your edition
All financial news and data tailored to specific country editions
